Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2026-04-19 @ 7:17 PM
Study NCT ID:
NCT00935792
Status:
COMPLETED
Last Update Posted:
2017-09-26
First Post:
2009-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Mayo Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MC088C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None